What is the equity of Aurisco Pharmaceutical Co this year?
Aurisco Pharmaceutical Co has equity of 1.97 B CNY this year.
Aurisco Pharmaceutical Co Equity 2024
Aurisco Pharmaceutical Co Equity
1.97 B CNY
Aurisco Pharmaceutical Co Dividend yield
0.7 %
Ticker
605116.SS
ISIN
CNE1000042S4
In 2024, Aurisco Pharmaceutical Co's equity was 1.97 B CNY, a 17.38% increase from the 1.68 B CNY equity in the previous year.
Aurisco Pharmaceutical Co Aktienanalyse
What does Aurisco Pharmaceutical Co do?
Aurisco Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Aurisco Pharmaceutical Co's Equity
Aurisco Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aurisco Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Aurisco Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Aurisco Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Aurisco Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Aurisco Pharmaceutical Co Stock
What was the equity of Aurisco Pharmaceutical Co compared to the previous year?
The equity of Aurisco Pharmaceutical Co has increased/decreased by 17.38% increased compared to the previous year.
What impact does a high equity have on investors of Aurisco Pharmaceutical Co?
A high equity is advantageous for investors of Aurisco Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Aurisco Pharmaceutical Co?
A low equity can be a risk for investors of Aurisco Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Aurisco Pharmaceutical Co affect the company?
An increase in equity of Aurisco Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Aurisco Pharmaceutical Co affect the company?
A reduction in equity of Aurisco Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Aurisco Pharmaceutical Co?
Some factors that can affect the equity of Aurisco Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Aurisco Pharmaceutical Co so important for investors?
The equity of Aurisco Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Aurisco Pharmaceutical Co take to change the equity?
To change equity, Aurisco Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Aurisco Pharmaceutical Co pay?
Over the past 12 months, Aurisco Pharmaceutical Co paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 0.7 %. For the coming 12 months, Aurisco Pharmaceutical Co is expected to pay a dividend of 0.17 CNY.
What is the dividend yield of Aurisco Pharmaceutical Co?
The current dividend yield of Aurisco Pharmaceutical Co is 0.7 %.
When does Aurisco Pharmaceutical Co pay dividends?
Aurisco Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aurisco Pharmaceutical Co?
Aurisco Pharmaceutical Co paid dividends every year for the past 5 years.
What is the dividend of Aurisco Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 0.76 %.
In which sector is Aurisco Pharmaceutical Co located?
Aurisco Pharmaceutical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aurisco Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aurisco Pharmaceutical Co from 5/22/2023 amounting to 0.16 CNY, you needed to have the stock in your portfolio before the ex-date on 5/22/2023.
When did Aurisco Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 5/22/2023.
What was the dividend of Aurisco Pharmaceutical Co in the year 2023?
In the year 2023, Aurisco Pharmaceutical Co distributed 0.13 CNY as dividends.
In which currency does Aurisco Pharmaceutical Co pay out the dividend?
The dividends of Aurisco Pharmaceutical Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aurisco Pharmaceutical Co
Our stock analysis for Aurisco Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aurisco Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Aurisco Pharmaceutical Co Revenue
- Aurisco Pharmaceutical Co Net Income
- Aurisco Pharmaceutical Co P/E
- Aurisco Pharmaceutical Co P/S
- Aurisco Pharmaceutical Co EBIT
- Aurisco Pharmaceutical Co Dividend
- Aurisco Pharmaceutical Co Stocks
- Aurisco Pharmaceutical Co Market capitalization
- Aurisco Pharmaceutical Co Debt
- Aurisco Pharmaceutical Co Liabilities
- Aurisco Pharmaceutical Co Equity
- Aurisco Pharmaceutical Co AAQS
- Aurisco Pharmaceutical Co Employees
- Aurisco Pharmaceutical Co ROE
- Aurisco Pharmaceutical Co ROA
- Aurisco Pharmaceutical Co ROCE